News Summary

NanoTess, a Calgary-based company, has developed NanoSALV, a groundbreaking gel that aids in the healing of chronic wounds, skin injuries, and infections. Co-founded by Julian Mulia, a chemical and software engineer, NanoSALV is a Health Canada-authorized medical device utilizing catalytic technology to enhance the natural wound healing process. This innovative product has garnered both national and international recognition, with interest from doctors worldwide. NanoSALV has been effective in treating complex wounds resistant to other treatments, significantly reducing wound size and improving patient quality of life. The gel is available in various sizes and does not require a prescription, positioning NanoTess as a promising player in the global healthcare market.